Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
10,154
archived clinical trials in
Other Indications

Azacitidine and Combination Chemotherapy in Treating Infants With Acute Lymphoblastic Leukemia and KMT2A Gene Rearrangement
A Groupwide Pilot Study to Test the Tolerability and Biologic Activity of the Addition of Azacitidine (NSC# 102816) to Chemotherapy in Infants With Acute Lymphoblastic Leukemia (ALL) and KMT2A (MLL) Gene Rearrangement
Status: Enrolling
Updated:  12/31/1969
Montefiore Medical Center - Moses Campus
1294
mi
from
Bronx, NY
Azacitidine and Combination Chemotherapy in Treating Infants With Acute Lymphoblastic Leukemia and KMT2A Gene Rearrangement
A Groupwide Pilot Study to Test the Tolerability and Biologic Activity of the Addition of Azacitidine (NSC# 102816) to Chemotherapy in Infants With Acute Lymphoblastic Leukemia (ALL) and KMT2A (MLL) Gene Rearrangement
Status: Enrolling
Updated: 12/31/1969
Montefiore Medical Center - Moses Campus
1294
mi
from
Bronx, NY
Click here to add this to my saved trials
Azacitidine and Combination Chemotherapy in Treating Infants With Acute Lymphoblastic Leukemia and KMT2A Gene Rearrangement
A Groupwide Pilot Study to Test the Tolerability and Biologic Activity of the Addition of Azacitidine (NSC# 102816) to Chemotherapy in Infants With Acute Lymphoblastic Leukemia (ALL) and KMT2A (MLL) Gene Rearrangement
Status: Enrolling
Updated:  12/31/1969
Kaiser Permanente Downey Medical Center
1165
mi
from
Downey, CA
Azacitidine and Combination Chemotherapy in Treating Infants With Acute Lymphoblastic Leukemia and KMT2A Gene Rearrangement
A Groupwide Pilot Study to Test the Tolerability and Biologic Activity of the Addition of Azacitidine (NSC# 102816) to Chemotherapy in Infants With Acute Lymphoblastic Leukemia (ALL) and KMT2A (MLL) Gene Rearrangement
Status: Enrolling
Updated: 12/31/1969
Kaiser Permanente Downey Medical Center
1165
mi
from
Downey, CA
Click here to add this to my saved trials
Azacitidine and Combination Chemotherapy in Treating Infants With Acute Lymphoblastic Leukemia and KMT2A Gene Rearrangement
A Groupwide Pilot Study to Test the Tolerability and Biologic Activity of the Addition of Azacitidine (NSC# 102816) to Chemotherapy in Infants With Acute Lymphoblastic Leukemia (ALL) and KMT2A (MLL) Gene Rearrangement
Status: Enrolling
Updated:  12/31/1969
University of Wisconsin Hospital and Clinics
574
mi
from
Madison, WI
Azacitidine and Combination Chemotherapy in Treating Infants With Acute Lymphoblastic Leukemia and KMT2A Gene Rearrangement
A Groupwide Pilot Study to Test the Tolerability and Biologic Activity of the Addition of Azacitidine (NSC# 102816) to Chemotherapy in Infants With Acute Lymphoblastic Leukemia (ALL) and KMT2A (MLL) Gene Rearrangement
Status: Enrolling
Updated: 12/31/1969
University of Wisconsin Hospital and Clinics
574
mi
from
Madison, WI
Click here to add this to my saved trials
Azacitidine and Combination Chemotherapy in Treating Infants With Acute Lymphoblastic Leukemia and KMT2A Gene Rearrangement
A Groupwide Pilot Study to Test the Tolerability and Biologic Activity of the Addition of Azacitidine (NSC# 102816) to Chemotherapy in Infants With Acute Lymphoblastic Leukemia (ALL) and KMT2A (MLL) Gene Rearrangement
Status: Enrolling
Updated:  12/31/1969
Duke Univ Med Ctr
1052
mi
from
Durham, NC
Azacitidine and Combination Chemotherapy in Treating Infants With Acute Lymphoblastic Leukemia and KMT2A Gene Rearrangement
A Groupwide Pilot Study to Test the Tolerability and Biologic Activity of the Addition of Azacitidine (NSC# 102816) to Chemotherapy in Infants With Acute Lymphoblastic Leukemia (ALL) and KMT2A (MLL) Gene Rearrangement
Status: Enrolling
Updated: 12/31/1969
Duke Univ Med Ctr
1052
mi
from
Durham, NC
Click here to add this to my saved trials
Azacitidine and Combination Chemotherapy in Treating Infants With Acute Lymphoblastic Leukemia and KMT2A Gene Rearrangement
A Groupwide Pilot Study to Test the Tolerability and Biologic Activity of the Addition of Azacitidine (NSC# 102816) to Chemotherapy in Infants With Acute Lymphoblastic Leukemia (ALL) and KMT2A (MLL) Gene Rearrangement
Status: Enrolling
Updated:  12/31/1969
Cedars-Sinai Medical Center
1168
mi
from
Los Angeles, CA
Azacitidine and Combination Chemotherapy in Treating Infants With Acute Lymphoblastic Leukemia and KMT2A Gene Rearrangement
A Groupwide Pilot Study to Test the Tolerability and Biologic Activity of the Addition of Azacitidine (NSC# 102816) to Chemotherapy in Infants With Acute Lymphoblastic Leukemia (ALL) and KMT2A (MLL) Gene Rearrangement
Status: Enrolling
Updated: 12/31/1969
Cedars-Sinai Medical Center
1168
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Azacitidine and Combination Chemotherapy in Treating Infants With Acute Lymphoblastic Leukemia and KMT2A Gene Rearrangement
A Groupwide Pilot Study to Test the Tolerability and Biologic Activity of the Addition of Azacitidine (NSC# 102816) to Chemotherapy in Infants With Acute Lymphoblastic Leukemia (ALL) and KMT2A (MLL) Gene Rearrangement
Status: Enrolling
Updated:  12/31/1969
Saint Joseph's Regional Medical Center
1278
mi
from
Paterson, NJ
Azacitidine and Combination Chemotherapy in Treating Infants With Acute Lymphoblastic Leukemia and KMT2A Gene Rearrangement
A Groupwide Pilot Study to Test the Tolerability and Biologic Activity of the Addition of Azacitidine (NSC# 102816) to Chemotherapy in Infants With Acute Lymphoblastic Leukemia (ALL) and KMT2A (MLL) Gene Rearrangement
Status: Enrolling
Updated: 12/31/1969
Saint Joseph's Regional Medical Center
1278
mi
from
Paterson, NJ
Click here to add this to my saved trials
Azacitidine and Combination Chemotherapy in Treating Infants With Acute Lymphoblastic Leukemia and KMT2A Gene Rearrangement
A Groupwide Pilot Study to Test the Tolerability and Biologic Activity of the Addition of Azacitidine (NSC# 102816) to Chemotherapy in Infants With Acute Lymphoblastic Leukemia (ALL) and KMT2A (MLL) Gene Rearrangement
Status: Enrolling
Updated:  12/31/1969
Ascension Saint John Hospital
841
mi
from
Detroit, MI
Azacitidine and Combination Chemotherapy in Treating Infants With Acute Lymphoblastic Leukemia and KMT2A Gene Rearrangement
A Groupwide Pilot Study to Test the Tolerability and Biologic Activity of the Addition of Azacitidine (NSC# 102816) to Chemotherapy in Infants With Acute Lymphoblastic Leukemia (ALL) and KMT2A (MLL) Gene Rearrangement
Status: Enrolling
Updated: 12/31/1969
Ascension Saint John Hospital
841
mi
from
Detroit, MI
Click here to add this to my saved trials
Azacitidine and Combination Chemotherapy in Treating Infants With Acute Lymphoblastic Leukemia and KMT2A Gene Rearrangement
A Groupwide Pilot Study to Test the Tolerability and Biologic Activity of the Addition of Azacitidine (NSC# 102816) to Chemotherapy in Infants With Acute Lymphoblastic Leukemia (ALL) and KMT2A (MLL) Gene Rearrangement
Status: Enrolling
Updated:  12/31/1969
Valley Children's Hospital
1219
mi
from
Madera, CA
Azacitidine and Combination Chemotherapy in Treating Infants With Acute Lymphoblastic Leukemia and KMT2A Gene Rearrangement
A Groupwide Pilot Study to Test the Tolerability and Biologic Activity of the Addition of Azacitidine (NSC# 102816) to Chemotherapy in Infants With Acute Lymphoblastic Leukemia (ALL) and KMT2A (MLL) Gene Rearrangement
Status: Enrolling
Updated: 12/31/1969
Valley Children's Hospital
1219
mi
from
Madera, CA
Click here to add this to my saved trials
Azacitidine and Combination Chemotherapy in Treating Infants With Acute Lymphoblastic Leukemia and KMT2A Gene Rearrangement
A Groupwide Pilot Study to Test the Tolerability and Biologic Activity of the Addition of Azacitidine (NSC# 102816) to Chemotherapy in Infants With Acute Lymphoblastic Leukemia (ALL) and KMT2A (MLL) Gene Rearrangement
Status: Enrolling
Updated:  12/31/1969
Walter Reed National Military Medical Center
1123
mi
from
Bethesda, MD
Azacitidine and Combination Chemotherapy in Treating Infants With Acute Lymphoblastic Leukemia and KMT2A Gene Rearrangement
A Groupwide Pilot Study to Test the Tolerability and Biologic Activity of the Addition of Azacitidine (NSC# 102816) to Chemotherapy in Infants With Acute Lymphoblastic Leukemia (ALL) and KMT2A (MLL) Gene Rearrangement
Status: Enrolling
Updated: 12/31/1969
Walter Reed National Military Medical Center
1123
mi
from
Bethesda, MD
Click here to add this to my saved trials
Azacitidine and Combination Chemotherapy in Treating Infants With Acute Lymphoblastic Leukemia and KMT2A Gene Rearrangement
A Groupwide Pilot Study to Test the Tolerability and Biologic Activity of the Addition of Azacitidine (NSC# 102816) to Chemotherapy in Infants With Acute Lymphoblastic Leukemia (ALL) and KMT2A (MLL) Gene Rearrangement
Status: Enrolling
Updated:  12/31/1969
Alliance for Childhood Diseases/Cure 4 the Kids Foundation
960
mi
from
Las Vegas, NV
Azacitidine and Combination Chemotherapy in Treating Infants With Acute Lymphoblastic Leukemia and KMT2A Gene Rearrangement
A Groupwide Pilot Study to Test the Tolerability and Biologic Activity of the Addition of Azacitidine (NSC# 102816) to Chemotherapy in Infants With Acute Lymphoblastic Leukemia (ALL) and KMT2A (MLL) Gene Rearrangement
Status: Enrolling
Updated: 12/31/1969
Alliance for Childhood Diseases/Cure 4 the Kids Foundation
960
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Azacitidine and Combination Chemotherapy in Treating Infants With Acute Lymphoblastic Leukemia and KMT2A Gene Rearrangement
A Groupwide Pilot Study to Test the Tolerability and Biologic Activity of the Addition of Azacitidine (NSC# 102816) to Chemotherapy in Infants With Acute Lymphoblastic Leukemia (ALL) and KMT2A (MLL) Gene Rearrangement
Status: Enrolling
Updated:  12/31/1969
USA Health Strada Patient Care Center
740
mi
from
Mobile, AL
Azacitidine and Combination Chemotherapy in Treating Infants With Acute Lymphoblastic Leukemia and KMT2A Gene Rearrangement
A Groupwide Pilot Study to Test the Tolerability and Biologic Activity of the Addition of Azacitidine (NSC# 102816) to Chemotherapy in Infants With Acute Lymphoblastic Leukemia (ALL) and KMT2A (MLL) Gene Rearrangement
Status: Enrolling
Updated: 12/31/1969
USA Health Strada Patient Care Center
740
mi
from
Mobile, AL
Click here to add this to my saved trials
Azacitidine and Combination Chemotherapy in Treating Infants With Acute Lymphoblastic Leukemia and KMT2A Gene Rearrangement
A Groupwide Pilot Study to Test the Tolerability and Biologic Activity of the Addition of Azacitidine (NSC# 102816) to Chemotherapy in Infants With Acute Lymphoblastic Leukemia (ALL) and KMT2A (MLL) Gene Rearrangement
Status: Enrolling
Updated:  12/31/1969
Marshfield Medical Center-Marshfield
621
mi
from
Marshfield, WI
Azacitidine and Combination Chemotherapy in Treating Infants With Acute Lymphoblastic Leukemia and KMT2A Gene Rearrangement
A Groupwide Pilot Study to Test the Tolerability and Biologic Activity of the Addition of Azacitidine (NSC# 102816) to Chemotherapy in Infants With Acute Lymphoblastic Leukemia (ALL) and KMT2A (MLL) Gene Rearrangement
Status: Enrolling
Updated: 12/31/1969
Marshfield Medical Center-Marshfield
621
mi
from
Marshfield, WI
Click here to add this to my saved trials
Azacitidine and Combination Chemotherapy in Treating Infants With Acute Lymphoblastic Leukemia and KMT2A Gene Rearrangement
A Groupwide Pilot Study to Test the Tolerability and Biologic Activity of the Addition of Azacitidine (NSC# 102816) to Chemotherapy in Infants With Acute Lymphoblastic Leukemia (ALL) and KMT2A (MLL) Gene Rearrangement
Status: Enrolling
Updated:  12/31/1969
Children's Mercy Hospitals and Clinics
197
mi
from
Kansas City, MO
Azacitidine and Combination Chemotherapy in Treating Infants With Acute Lymphoblastic Leukemia and KMT2A Gene Rearrangement
A Groupwide Pilot Study to Test the Tolerability and Biologic Activity of the Addition of Azacitidine (NSC# 102816) to Chemotherapy in Infants With Acute Lymphoblastic Leukemia (ALL) and KMT2A (MLL) Gene Rearrangement
Status: Enrolling
Updated: 12/31/1969
Children's Mercy Hospitals and Clinics
197
mi
from
Kansas City, MO
Click here to add this to my saved trials
Azacitidine and Combination Chemotherapy in Treating Infants With Acute Lymphoblastic Leukemia and KMT2A Gene Rearrangement
A Groupwide Pilot Study to Test the Tolerability and Biologic Activity of the Addition of Azacitidine (NSC# 102816) to Chemotherapy in Infants With Acute Lymphoblastic Leukemia (ALL) and KMT2A (MLL) Gene Rearrangement
Status: Enrolling
Updated:  12/31/1969
NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center
1290
mi
from
New York, NY
Azacitidine and Combination Chemotherapy in Treating Infants With Acute Lymphoblastic Leukemia and KMT2A Gene Rearrangement
A Groupwide Pilot Study to Test the Tolerability and Biologic Activity of the Addition of Azacitidine (NSC# 102816) to Chemotherapy in Infants With Acute Lymphoblastic Leukemia (ALL) and KMT2A (MLL) Gene Rearrangement
Status: Enrolling
Updated: 12/31/1969
NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center
1290
mi
from
New York, NY
Click here to add this to my saved trials
Clinical Trial of Sound-Based Versus Behavioral Therapy for Tinnitus
Clinical Trial of Sound-Based Versus Behavioral Therapy for Tinnitus
Status: Enrolling
Updated:  12/31/1969
VA Portland Health Care System, National Center for Rehabilitative Auditory Research
1383
mi
from
Portland, OR
Clinical Trial of Sound-Based Versus Behavioral Therapy for Tinnitus
Clinical Trial of Sound-Based Versus Behavioral Therapy for Tinnitus
Status: Enrolling
Updated: 12/31/1969
VA Portland Health Care System, National Center for Rehabilitative Auditory Research
1383
mi
from
Portland, OR
Click here to add this to my saved trials
A Two-Part Study to Investigate the Dose-Ranging Safety and Pharmacokinetics, Followed by the Efficacy and Safety of ZX008 (Fenfluramine Hydrochloride) Oral Solution as an Adjunctive Therapy in Children ≥2 Years Old and Young Adults With Dravet Syndrome
A Multicenter, 2-Cohort Trial to First Assess the Pharmacokinetic and Safety Profile of a Single Dose of ZX008 (Fenfluramine Hydrochloride) Oral Solution When Added to Standard of Care , Followed by a Randomized, Double-blind, Placebo-controlled Parallel Group Evaluation of the Efficacy, Safety, and Tolerability of ZX008 as Adjunctive Antiepileptic Therapy to Stiripentol Treatment in Children and Young Adults With Dravet Syndrome
Status: Enrolling
Updated:  12/31/1969
University of California at San Francisco
1341
mi
from
San Francisco, CA
A Two-Part Study to Investigate the Dose-Ranging Safety and Pharmacokinetics, Followed by the Efficacy and Safety of ZX008 (Fenfluramine Hydrochloride) Oral Solution as an Adjunctive Therapy in Children ≥2 Years Old and Young Adults With Dravet Syndrome
A Multicenter, 2-Cohort Trial to First Assess the Pharmacokinetic and Safety Profile of a Single Dose of ZX008 (Fenfluramine Hydrochloride) Oral Solution When Added to Standard of Care , Followed by a Randomized, Double-blind, Placebo-controlled Parallel Group Evaluation of the Efficacy, Safety, and Tolerability of ZX008 as Adjunctive Antiepileptic Therapy to Stiripentol Treatment in Children and Young Adults With Dravet Syndrome
Status: Enrolling
Updated: 12/31/1969
University of California at San Francisco
1341
mi
from
San Francisco, CA
Click here to add this to my saved trials
A Two-Part Study to Investigate the Dose-Ranging Safety and Pharmacokinetics, Followed by the Efficacy and Safety of ZX008 (Fenfluramine Hydrochloride) Oral Solution as an Adjunctive Therapy in Children ≥2 Years Old and Young Adults With Dravet Syndrome
A Multicenter, 2-Cohort Trial to First Assess the Pharmacokinetic and Safety Profile of a Single Dose of ZX008 (Fenfluramine Hydrochloride) Oral Solution When Added to Standard of Care , Followed by a Randomized, Double-blind, Placebo-controlled Parallel Group Evaluation of the Efficacy, Safety, and Tolerability of ZX008 as Adjunctive Antiepileptic Therapy to Stiripentol Treatment in Children and Young Adults With Dravet Syndrome
Status: Enrolling
Updated:  12/31/1969
Children's Hospital Colorado
400
mi
from
Aurora, CO
A Two-Part Study to Investigate the Dose-Ranging Safety and Pharmacokinetics, Followed by the Efficacy and Safety of ZX008 (Fenfluramine Hydrochloride) Oral Solution as an Adjunctive Therapy in Children ≥2 Years Old and Young Adults With Dravet Syndrome
A Multicenter, 2-Cohort Trial to First Assess the Pharmacokinetic and Safety Profile of a Single Dose of ZX008 (Fenfluramine Hydrochloride) Oral Solution When Added to Standard of Care , Followed by a Randomized, Double-blind, Placebo-controlled Parallel Group Evaluation of the Efficacy, Safety, and Tolerability of ZX008 as Adjunctive Antiepileptic Therapy to Stiripentol Treatment in Children and Young Adults With Dravet Syndrome
Status: Enrolling
Updated: 12/31/1969
Children's Hospital Colorado
400
mi
from
Aurora, CO
Click here to add this to my saved trials
A Two-Part Study to Investigate the Dose-Ranging Safety and Pharmacokinetics, Followed by the Efficacy and Safety of ZX008 (Fenfluramine Hydrochloride) Oral Solution as an Adjunctive Therapy in Children ≥2 Years Old and Young Adults With Dravet Syndrome
A Multicenter, 2-Cohort Trial to First Assess the Pharmacokinetic and Safety Profile of a Single Dose of ZX008 (Fenfluramine Hydrochloride) Oral Solution When Added to Standard of Care , Followed by a Randomized, Double-blind, Placebo-controlled Parallel Group Evaluation of the Efficacy, Safety, and Tolerability of ZX008 as Adjunctive Antiepileptic Therapy to Stiripentol Treatment in Children and Young Adults With Dravet Syndrome
Status: Enrolling
Updated:  12/31/1969
Ann & Robert Lurie Children's Hospital of Chicago
610
mi
from
Chicago, IL
A Two-Part Study to Investigate the Dose-Ranging Safety and Pharmacokinetics, Followed by the Efficacy and Safety of ZX008 (Fenfluramine Hydrochloride) Oral Solution as an Adjunctive Therapy in Children ≥2 Years Old and Young Adults With Dravet Syndrome
A Multicenter, 2-Cohort Trial to First Assess the Pharmacokinetic and Safety Profile of a Single Dose of ZX008 (Fenfluramine Hydrochloride) Oral Solution When Added to Standard of Care , Followed by a Randomized, Double-blind, Placebo-controlled Parallel Group Evaluation of the Efficacy, Safety, and Tolerability of ZX008 as Adjunctive Antiepileptic Therapy to Stiripentol Treatment in Children and Young Adults With Dravet Syndrome
Status: Enrolling
Updated: 12/31/1969
Ann & Robert Lurie Children's Hospital of Chicago
610
mi
from
Chicago, IL
Click here to add this to my saved trials
A Two-Part Study to Investigate the Dose-Ranging Safety and Pharmacokinetics, Followed by the Efficacy and Safety of ZX008 (Fenfluramine Hydrochloride) Oral Solution as an Adjunctive Therapy in Children ≥2 Years Old and Young Adults With Dravet Syndrome
A Multicenter, 2-Cohort Trial to First Assess the Pharmacokinetic and Safety Profile of a Single Dose of ZX008 (Fenfluramine Hydrochloride) Oral Solution When Added to Standard of Care , Followed by a Randomized, Double-blind, Placebo-controlled Parallel Group Evaluation of the Efficacy, Safety, and Tolerability of ZX008 as Adjunctive Antiepileptic Therapy to Stiripentol Treatment in Children and Young Adults With Dravet Syndrome
Status: Enrolling
Updated:  12/31/1969
The Mayo Clinic
515
mi
from
Rochester, MN
A Two-Part Study to Investigate the Dose-Ranging Safety and Pharmacokinetics, Followed by the Efficacy and Safety of ZX008 (Fenfluramine Hydrochloride) Oral Solution as an Adjunctive Therapy in Children ≥2 Years Old and Young Adults With Dravet Syndrome
A Multicenter, 2-Cohort Trial to First Assess the Pharmacokinetic and Safety Profile of a Single Dose of ZX008 (Fenfluramine Hydrochloride) Oral Solution When Added to Standard of Care , Followed by a Randomized, Double-blind, Placebo-controlled Parallel Group Evaluation of the Efficacy, Safety, and Tolerability of ZX008 as Adjunctive Antiepileptic Therapy to Stiripentol Treatment in Children and Young Adults With Dravet Syndrome
Status: Enrolling
Updated: 12/31/1969
The Mayo Clinic
515
mi
from
Rochester, MN
Click here to add this to my saved trials
A Two-Part Study to Investigate the Dose-Ranging Safety and Pharmacokinetics, Followed by the Efficacy and Safety of ZX008 (Fenfluramine Hydrochloride) Oral Solution as an Adjunctive Therapy in Children ≥2 Years Old and Young Adults With Dravet Syndrome
A Multicenter, 2-Cohort Trial to First Assess the Pharmacokinetic and Safety Profile of a Single Dose of ZX008 (Fenfluramine Hydrochloride) Oral Solution When Added to Standard of Care , Followed by a Randomized, Double-blind, Placebo-controlled Parallel Group Evaluation of the Efficacy, Safety, and Tolerability of ZX008 as Adjunctive Antiepileptic Therapy to Stiripentol Treatment in Children and Young Adults With Dravet Syndrome
Status: Enrolling
Updated:  12/31/1969
British Columbia Children's Hospital
1486
mi
from
Vancouver,
A Two-Part Study to Investigate the Dose-Ranging Safety and Pharmacokinetics, Followed by the Efficacy and Safety of ZX008 (Fenfluramine Hydrochloride) Oral Solution as an Adjunctive Therapy in Children ≥2 Years Old and Young Adults With Dravet Syndrome
A Multicenter, 2-Cohort Trial to First Assess the Pharmacokinetic and Safety Profile of a Single Dose of ZX008 (Fenfluramine Hydrochloride) Oral Solution When Added to Standard of Care , Followed by a Randomized, Double-blind, Placebo-controlled Parallel Group Evaluation of the Efficacy, Safety, and Tolerability of ZX008 as Adjunctive Antiepileptic Therapy to Stiripentol Treatment in Children and Young Adults With Dravet Syndrome
Status: Enrolling
Updated: 12/31/1969
British Columbia Children's Hospital
1486
mi
from
Vancouver,
Click here to add this to my saved trials
Trial of Cannabidiol (CBD; GWP42003-P) for Infantile Spasms (GWPCARE7)
A Randomized, Double-blind, Placebo-controlled Trial to Investigate the Efficacy and Safety of Cannabidiol (CBD; GWP42003-P) in Infants With Infantile Spasms Following an Initial Open-label Pilot Study
Status: Enrolling
Updated:  12/31/1969
Wake Forest Baptist Medical Center
976
mi
from
Winston-Salem, NC
Trial of Cannabidiol (CBD; GWP42003-P) for Infantile Spasms (GWPCARE7)
A Randomized, Double-blind, Placebo-controlled Trial to Investigate the Efficacy and Safety of Cannabidiol (CBD; GWP42003-P) in Infants With Infantile Spasms Following an Initial Open-label Pilot Study
Status: Enrolling
Updated: 12/31/1969
Wake Forest Baptist Medical Center
976
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Trial of Cannabidiol (CBD; GWP42003-P) for Infantile Spasms (GWPCARE7)
A Randomized, Double-blind, Placebo-controlled Trial to Investigate the Efficacy and Safety of Cannabidiol (CBD; GWP42003-P) in Infants With Infantile Spasms Following an Initial Open-label Pilot Study
Status: Enrolling
Updated:  12/31/1969
Nationwide Children's Hospital
811
mi
from
Columbus, OH
Trial of Cannabidiol (CBD; GWP42003-P) for Infantile Spasms (GWPCARE7)
A Randomized, Double-blind, Placebo-controlled Trial to Investigate the Efficacy and Safety of Cannabidiol (CBD; GWP42003-P) in Infants With Infantile Spasms Following an Initial Open-label Pilot Study
Status: Enrolling
Updated: 12/31/1969
Nationwide Children's Hospital
811
mi
from
Columbus, OH
Click here to add this to my saved trials
Trial of Cannabidiol (CBD; GWP42003-P) for Infantile Spasms (GWPCARE7)
A Randomized, Double-blind, Placebo-controlled Trial to Investigate the Efficacy and Safety of Cannabidiol (CBD; GWP42003-P) in Infants With Infantile Spasms Following an Initial Open-label Pilot Study
Status: Enrolling
Updated:  12/31/1969
Le Bonheur Children's Hospital
467
mi
from
Memphis, TN
Trial of Cannabidiol (CBD; GWP42003-P) for Infantile Spasms (GWPCARE7)
A Randomized, Double-blind, Placebo-controlled Trial to Investigate the Efficacy and Safety of Cannabidiol (CBD; GWP42003-P) in Infants With Infantile Spasms Following an Initial Open-label Pilot Study
Status: Enrolling
Updated: 12/31/1969
Le Bonheur Children's Hospital
467
mi
from
Memphis, TN
Click here to add this to my saved trials
Trial of Cannabidiol (CBD; GWP42003-P) for Infantile Spasms (GWPCARE7)
A Randomized, Double-blind, Placebo-controlled Trial to Investigate the Efficacy and Safety of Cannabidiol (CBD; GWP42003-P) in Infants With Infantile Spasms Following an Initial Open-label Pilot Study
Status: Enrolling
Updated:  12/31/1969
Valley Health Clinical Research
1065
mi
from
Winchester, VA
Trial of Cannabidiol (CBD; GWP42003-P) for Infantile Spasms (GWPCARE7)
A Randomized, Double-blind, Placebo-controlled Trial to Investigate the Efficacy and Safety of Cannabidiol (CBD; GWP42003-P) in Infants With Infantile Spasms Following an Initial Open-label Pilot Study
Status: Enrolling
Updated: 12/31/1969
Valley Health Clinical Research
1065
mi
from
Winchester, VA
Click here to add this to my saved trials
Trial of Cannabidiol (CBD; GWP42003-P) for Infantile Spasms (GWPCARE7)
A Randomized, Double-blind, Placebo-controlled Trial to Investigate the Efficacy and Safety of Cannabidiol (CBD; GWP42003-P) in Infants With Infantile Spasms Following an Initial Open-label Pilot Study
Status: Enrolling
Updated:  12/31/1969
Uniwersyteckie Centrum Kliniczne
mi
from
Gda?sk,
Trial of Cannabidiol (CBD; GWP42003-P) for Infantile Spasms (GWPCARE7)
A Randomized, Double-blind, Placebo-controlled Trial to Investigate the Efficacy and Safety of Cannabidiol (CBD; GWP42003-P) in Infants With Infantile Spasms Following an Initial Open-label Pilot Study
Status: Enrolling
Updated: 12/31/1969
Uniwersyteckie Centrum Kliniczne
mi
from
Gda?sk,
Click here to add this to my saved trials
Phase 3 Trial of Cannabidiol (CBD; GWP42003-P) for Infantile Spasms: Open-label Extension Phase (GWPCARE7)
A Randomized, Double-blind, Placebo-controlled Trial to Investigate the Efficacy and Safety of Cannabidiol (CBD; GWP42003-P) in Infants With Infantile Spasms Following an Initial Open-label Pilot Study
Status: Enrolling
Updated:  12/31/1969
Wake Forest Baptist Medical Center
976
mi
from
Winston-Salem, NC
Phase 3 Trial of Cannabidiol (CBD; GWP42003-P) for Infantile Spasms: Open-label Extension Phase (GWPCARE7)
A Randomized, Double-blind, Placebo-controlled Trial to Investigate the Efficacy and Safety of Cannabidiol (CBD; GWP42003-P) in Infants With Infantile Spasms Following an Initial Open-label Pilot Study
Status: Enrolling
Updated: 12/31/1969
Wake Forest Baptist Medical Center
976
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Phase 3 Trial of Cannabidiol (CBD; GWP42003-P) for Infantile Spasms: Open-label Extension Phase (GWPCARE7)
A Randomized, Double-blind, Placebo-controlled Trial to Investigate the Efficacy and Safety of Cannabidiol (CBD; GWP42003-P) in Infants With Infantile Spasms Following an Initial Open-label Pilot Study
Status: Enrolling
Updated:  12/31/1969
Nationwide Children's Hospital
811
mi
from
Columbus, OH
Phase 3 Trial of Cannabidiol (CBD; GWP42003-P) for Infantile Spasms: Open-label Extension Phase (GWPCARE7)
A Randomized, Double-blind, Placebo-controlled Trial to Investigate the Efficacy and Safety of Cannabidiol (CBD; GWP42003-P) in Infants With Infantile Spasms Following an Initial Open-label Pilot Study
Status: Enrolling
Updated: 12/31/1969
Nationwide Children's Hospital
811
mi
from
Columbus, OH
Click here to add this to my saved trials
Phase 3 Trial of Cannabidiol (CBD; GWP42003-P) for Infantile Spasms: Open-label Extension Phase (GWPCARE7)
A Randomized, Double-blind, Placebo-controlled Trial to Investigate the Efficacy and Safety of Cannabidiol (CBD; GWP42003-P) in Infants With Infantile Spasms Following an Initial Open-label Pilot Study
Status: Enrolling
Updated:  12/31/1969
Le Bonheur Children's Hospital
467
mi
from
Memphis, TN
Phase 3 Trial of Cannabidiol (CBD; GWP42003-P) for Infantile Spasms: Open-label Extension Phase (GWPCARE7)
A Randomized, Double-blind, Placebo-controlled Trial to Investigate the Efficacy and Safety of Cannabidiol (CBD; GWP42003-P) in Infants With Infantile Spasms Following an Initial Open-label Pilot Study
Status: Enrolling
Updated: 12/31/1969
Le Bonheur Children's Hospital
467
mi
from
Memphis, TN
Click here to add this to my saved trials
Phase 3 Trial of Cannabidiol (CBD; GWP42003-P) for Infantile Spasms: Open-label Extension Phase (GWPCARE7)
A Randomized, Double-blind, Placebo-controlled Trial to Investigate the Efficacy and Safety of Cannabidiol (CBD; GWP42003-P) in Infants With Infantile Spasms Following an Initial Open-label Pilot Study
Status: Enrolling
Updated:  12/31/1969
Valley Health Clinical Research
1065
mi
from
Winchester, VA
Phase 3 Trial of Cannabidiol (CBD; GWP42003-P) for Infantile Spasms: Open-label Extension Phase (GWPCARE7)
A Randomized, Double-blind, Placebo-controlled Trial to Investigate the Efficacy and Safety of Cannabidiol (CBD; GWP42003-P) in Infants With Infantile Spasms Following an Initial Open-label Pilot Study
Status: Enrolling
Updated: 12/31/1969
Valley Health Clinical Research
1065
mi
from
Winchester, VA
Click here to add this to my saved trials
Phase 3 Trial of Cannabidiol (CBD; GWP42003-P) for Infantile Spasms: Open-label Extension Phase (GWPCARE7)
A Randomized, Double-blind, Placebo-controlled Trial to Investigate the Efficacy and Safety of Cannabidiol (CBD; GWP42003-P) in Infants With Infantile Spasms Following an Initial Open-label Pilot Study
Status: Enrolling
Updated:  12/31/1969
Uniwersyteckie Centrum Kliniczne
mi
from
Gda?sk,
Phase 3 Trial of Cannabidiol (CBD; GWP42003-P) for Infantile Spasms: Open-label Extension Phase (GWPCARE7)
A Randomized, Double-blind, Placebo-controlled Trial to Investigate the Efficacy and Safety of Cannabidiol (CBD; GWP42003-P) in Infants With Infantile Spasms Following an Initial Open-label Pilot Study
Status: Enrolling
Updated: 12/31/1969
Uniwersyteckie Centrum Kliniczne
mi
from
Gda?sk,
Click here to add this to my saved trials
A Study to Evaluate the Safety and Microbiology of C16G2 Varnish Administered in Multiple Doses to Dental Subjects
A Phase 2, Single-blind, Randomized, Placebo-controlled Study to Evaluate the Safety and Microbiology of C16G2 Varnish Administered in Multiple Doses to Adolescent and Adult Dental Subjects
Status: Enrolling
Updated:  12/31/1969
John F. Pittaway, DMD
1098
mi
from
Kalispell, MT
A Study to Evaluate the Safety and Microbiology of C16G2 Varnish Administered in Multiple Doses to Dental Subjects
A Phase 2, Single-blind, Randomized, Placebo-controlled Study to Evaluate the Safety and Microbiology of C16G2 Varnish Administered in Multiple Doses to Adolescent and Adult Dental Subjects
Status: Enrolling
Updated: 12/31/1969
John F. Pittaway, DMD
1098
mi
from
Kalispell, MT
Click here to add this to my saved trials
A Study to Evaluate the Safety and Microbiology of C16G2 Varnish Administered in Multiple Doses to Dental Subjects
A Phase 2, Single-blind, Randomized, Placebo-controlled Study to Evaluate the Safety and Microbiology of C16G2 Varnish Administered in Multiple Doses to Adolescent and Adult Dental Subjects
Status: Enrolling
Updated:  12/31/1969
Jacqueline Kleven, DDS
340
mi
from
Bedford, TX
A Study to Evaluate the Safety and Microbiology of C16G2 Varnish Administered in Multiple Doses to Dental Subjects
A Phase 2, Single-blind, Randomized, Placebo-controlled Study to Evaluate the Safety and Microbiology of C16G2 Varnish Administered in Multiple Doses to Adolescent and Adult Dental Subjects
Status: Enrolling
Updated: 12/31/1969
Jacqueline Kleven, DDS
340
mi
from
Bedford, TX
Click here to add this to my saved trials
A Study to Evaluate the Safety and Microbiology of C16G2 Varnish Administered in Multiple Doses to Dental Subjects
A Phase 2, Single-blind, Randomized, Placebo-controlled Study to Evaluate the Safety and Microbiology of C16G2 Varnish Administered in Multiple Doses to Adolescent and Adult Dental Subjects
Status: Enrolling
Updated:  12/31/1969
Anthony Henegar, DDS, PA
337
mi
from
Irving, TX
A Study to Evaluate the Safety and Microbiology of C16G2 Varnish Administered in Multiple Doses to Dental Subjects
A Phase 2, Single-blind, Randomized, Placebo-controlled Study to Evaluate the Safety and Microbiology of C16G2 Varnish Administered in Multiple Doses to Adolescent and Adult Dental Subjects
Status: Enrolling
Updated: 12/31/1969
Anthony Henegar, DDS, PA
337
mi
from
Irving, TX
Click here to add this to my saved trials
A Study to Evaluate the Microbiology, Safety and Tolerability of C16G2 Dental Strip Application
A Phase 2, Single-blind, Randomized, Placebo-controlled Study to Evaluate the Microbiology, Safety and Tolerability of C16G2 Strip Administered in Multiple Doses to Adolescent and Adult Dental Subjects
Status: Enrolling
Updated:  12/31/1969
John F. Pittaway, DMD
1098
mi
from
Kalispell, MT
A Study to Evaluate the Microbiology, Safety and Tolerability of C16G2 Dental Strip Application
A Phase 2, Single-blind, Randomized, Placebo-controlled Study to Evaluate the Microbiology, Safety and Tolerability of C16G2 Strip Administered in Multiple Doses to Adolescent and Adult Dental Subjects
Status: Enrolling
Updated: 12/31/1969
John F. Pittaway, DMD
1098
mi
from
Kalispell, MT
Click here to add this to my saved trials
A Study to Evaluate the Microbiology, Safety and Tolerability of C16G2 Dental Strip Application
A Phase 2, Single-blind, Randomized, Placebo-controlled Study to Evaluate the Microbiology, Safety and Tolerability of C16G2 Strip Administered in Multiple Doses to Adolescent and Adult Dental Subjects
Status: Enrolling
Updated:  12/31/1969
Jacqueline Kleven, DDS
340
mi
from
Bedford, TX
A Study to Evaluate the Microbiology, Safety and Tolerability of C16G2 Dental Strip Application
A Phase 2, Single-blind, Randomized, Placebo-controlled Study to Evaluate the Microbiology, Safety and Tolerability of C16G2 Strip Administered in Multiple Doses to Adolescent and Adult Dental Subjects
Status: Enrolling
Updated: 12/31/1969
Jacqueline Kleven, DDS
340
mi
from
Bedford, TX
Click here to add this to my saved trials
A Study to Evaluate the Microbiology, Safety and Tolerability of C16G2 Dental Strip Application
A Phase 2, Single-blind, Randomized, Placebo-controlled Study to Evaluate the Microbiology, Safety and Tolerability of C16G2 Strip Administered in Multiple Doses to Adolescent and Adult Dental Subjects
Status: Enrolling
Updated:  12/31/1969
Anthony Henegar, DDS, PA
337
mi
from
Irving, TX
A Study to Evaluate the Microbiology, Safety and Tolerability of C16G2 Dental Strip Application
A Phase 2, Single-blind, Randomized, Placebo-controlled Study to Evaluate the Microbiology, Safety and Tolerability of C16G2 Strip Administered in Multiple Doses to Adolescent and Adult Dental Subjects
Status: Enrolling
Updated: 12/31/1969
Anthony Henegar, DDS, PA
337
mi
from
Irving, TX
Click here to add this to my saved trials
A Phase I/II Trial for Intravitreous Treatment of Severe Ocular Von Hippel-Lindau Disease Using a Combination of the PDGF Antagonist E10030 and the VEGF Antagonist Ranibizumab
A Phase I/II Trial for Intravitreous Treatment of Severe Ocular Von Hippel-Lindau Disease Using a Combination of the PDGF Antagonist E10030 and the VEGF Antagonist Ranibizumab
Status: Enrolling
Updated:  12/31/1969
National Institutes of Health Clinical Center
1123
mi
from
Bethesda, MD
A Phase I/II Trial for Intravitreous Treatment of Severe Ocular Von Hippel-Lindau Disease Using a Combination of the PDGF Antagonist E10030 and the VEGF Antagonist Ranibizumab
A Phase I/II Trial for Intravitreous Treatment of Severe Ocular Von Hippel-Lindau Disease Using a Combination of the PDGF Antagonist E10030 and the VEGF Antagonist Ranibizumab
Status: Enrolling
Updated: 12/31/1969
National Institutes of Health Clinical Center
1123
mi
from
Bethesda, MD
Click here to add this to my saved trials
Exercise Testing for Early Stage Breast Cancer Patients Receiving Radiation Treatment
Pilot Study for Assessment of Exercise Capacity in Breast Cancer Patients With Radiotherapy-Related Fatigue
Status: Enrolling
Updated:  12/31/1969
Memorial Sloan Kettering Cancer Center
1289
mi
from
New York, NY
Exercise Testing for Early Stage Breast Cancer Patients Receiving Radiation Treatment
Pilot Study for Assessment of Exercise Capacity in Breast Cancer Patients With Radiotherapy-Related Fatigue
Status: Enrolling
Updated: 12/31/1969
Memorial Sloan Kettering Cancer Center
1289
mi
from
New York, NY
Click here to add this to my saved trials
Exercise Testing for Early Stage Breast Cancer Patients Receiving Radiation Treatment
Pilot Study for Assessment of Exercise Capacity in Breast Cancer Patients With Radiotherapy-Related Fatigue
Status: Enrolling
Updated:  12/31/1969
Memoral Sloan Kettering Basking Ridge (Consent only)
1256
mi
from
Basking Ridge, NJ
Exercise Testing for Early Stage Breast Cancer Patients Receiving Radiation Treatment
Pilot Study for Assessment of Exercise Capacity in Breast Cancer Patients With Radiotherapy-Related Fatigue
Status: Enrolling
Updated: 12/31/1969
Memoral Sloan Kettering Basking Ridge (Consent only)
1256
mi
from
Basking Ridge, NJ
Click here to add this to my saved trials
Exercise Testing for Early Stage Breast Cancer Patients Receiving Radiation Treatment
Pilot Study for Assessment of Exercise Capacity in Breast Cancer Patients With Radiotherapy-Related Fatigue
Status: Enrolling
Updated:  12/31/1969
Memorial Sloan Kettering Monmouth (Consent only)
1278
mi
from
Middletown, NJ
Exercise Testing for Early Stage Breast Cancer Patients Receiving Radiation Treatment
Pilot Study for Assessment of Exercise Capacity in Breast Cancer Patients With Radiotherapy-Related Fatigue
Status: Enrolling
Updated: 12/31/1969
Memorial Sloan Kettering Monmouth (Consent only)
1278
mi
from
Middletown, NJ
Click here to add this to my saved trials
Exercise Testing for Early Stage Breast Cancer Patients Receiving Radiation Treatment
Pilot Study for Assessment of Exercise Capacity in Breast Cancer Patients With Radiotherapy-Related Fatigue
Status: Enrolling
Updated:  12/31/1969
Memorial Sloan Kettering Bergen (Consent only)
1284
mi
from
Montvale, NJ
Exercise Testing for Early Stage Breast Cancer Patients Receiving Radiation Treatment
Pilot Study for Assessment of Exercise Capacity in Breast Cancer Patients With Radiotherapy-Related Fatigue
Status: Enrolling
Updated: 12/31/1969
Memorial Sloan Kettering Bergen (Consent only)
1284
mi
from
Montvale, NJ
Click here to add this to my saved trials
Exercise Testing for Early Stage Breast Cancer Patients Receiving Radiation Treatment
Pilot Study for Assessment of Exercise Capacity in Breast Cancer Patients With Radiotherapy-Related Fatigue
Status: Enrolling
Updated:  12/31/1969
Memorial Sloan Kettering Commack (Consent only)
1324
mi
from
Commack, NY
Exercise Testing for Early Stage Breast Cancer Patients Receiving Radiation Treatment
Pilot Study for Assessment of Exercise Capacity in Breast Cancer Patients With Radiotherapy-Related Fatigue
Status: Enrolling
Updated: 12/31/1969
Memorial Sloan Kettering Commack (Consent only)
1324
mi
from
Commack, NY
Click here to add this to my saved trials
Exercise Testing for Early Stage Breast Cancer Patients Receiving Radiation Treatment
Pilot Study for Assessment of Exercise Capacity in Breast Cancer Patients With Radiotherapy-Related Fatigue
Status: Enrolling
Updated:  12/31/1969
Memorial Sloan Kettering Westchester (Consent only)
1301
mi
from
Harrison, NY
Exercise Testing for Early Stage Breast Cancer Patients Receiving Radiation Treatment
Pilot Study for Assessment of Exercise Capacity in Breast Cancer Patients With Radiotherapy-Related Fatigue
Status: Enrolling
Updated: 12/31/1969
Memorial Sloan Kettering Westchester (Consent only)
1301
mi
from
Harrison, NY
Click here to add this to my saved trials
Exercise Testing for Early Stage Breast Cancer Patients Receiving Radiation Treatment
Pilot Study for Assessment of Exercise Capacity in Breast Cancer Patients With Radiotherapy-Related Fatigue
Status: Enrolling
Updated:  12/31/1969
Memorial Sloan Kettering Rockville Centre (Consent only)
1289
mi
from
Rockville Centre, NY
Exercise Testing for Early Stage Breast Cancer Patients Receiving Radiation Treatment
Pilot Study for Assessment of Exercise Capacity in Breast Cancer Patients With Radiotherapy-Related Fatigue
Status: Enrolling
Updated: 12/31/1969
Memorial Sloan Kettering Rockville Centre (Consent only)
1289
mi
from
Rockville Centre, NY
Click here to add this to my saved trials
Switching to Low Oxidant Content Cigarettes in Adult Smokers
Switching to Low Oxidant Content Cigarettes in Adult Smokers
Status: Enrolling
Updated:  12/31/1969
Penn State Hershey
1145
mi
from
Hershey, PA
Switching to Low Oxidant Content Cigarettes in Adult Smokers
Switching to Low Oxidant Content Cigarettes in Adult Smokers
Status: Enrolling
Updated: 12/31/1969
Penn State Hershey
1145
mi
from
Hershey, PA
Click here to add this to my saved trials
Early Auditory Referral in Primary Care
Early Auditory Referral in Primary Care (EAR-PC)
Status: Enrolling
Updated:  12/31/1969
Dominos Farms Family Medicine
810
mi
from
Ann Arbor, MI
Early Auditory Referral in Primary Care
Early Auditory Referral in Primary Care (EAR-PC)
Status: Enrolling
Updated: 12/31/1969
Dominos Farms Family Medicine
810
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Early Auditory Referral in Primary Care
Early Auditory Referral in Primary Care (EAR-PC)
Status: Enrolling
Updated:  12/31/1969
Chelsea Family Medicine
794
mi
from
Chelsea, MI
Early Auditory Referral in Primary Care
Early Auditory Referral in Primary Care (EAR-PC)
Status: Enrolling
Updated: 12/31/1969
Chelsea Family Medicine
794
mi
from
Chelsea, MI
Click here to add this to my saved trials
Early Auditory Referral in Primary Care
Early Auditory Referral in Primary Care (EAR-PC)
Status: Enrolling
Updated:  12/31/1969
Dexter Health Center
801
mi
from
Dexter, MI
Early Auditory Referral in Primary Care
Early Auditory Referral in Primary Care (EAR-PC)
Status: Enrolling
Updated: 12/31/1969
Dexter Health Center
801
mi
from
Dexter, MI
Click here to add this to my saved trials
Early Auditory Referral in Primary Care
Early Auditory Referral in Primary Care (EAR-PC)
Status: Enrolling
Updated:  12/31/1969
Livonia Health Center
827
mi
from
Livonia, MI
Early Auditory Referral in Primary Care
Early Auditory Referral in Primary Care (EAR-PC)
Status: Enrolling
Updated: 12/31/1969
Livonia Health Center
827
mi
from
Livonia, MI
Click here to add this to my saved trials
Early Auditory Referral in Primary Care
Early Auditory Referral in Primary Care (EAR-PC)
Status: Enrolling
Updated:  12/31/1969
Ypsilanti Health Center
812
mi
from
Ypsilanti, MI
Early Auditory Referral in Primary Care
Early Auditory Referral in Primary Care (EAR-PC)
Status: Enrolling
Updated: 12/31/1969
Ypsilanti Health Center
812
mi
from
Ypsilanti, MI
Click here to add this to my saved trials